187 related articles for article (PubMed ID: 31526091)
21. Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
Zhou ZD; Saw WT; Tan EK
Mol Neurobiol; 2017 Sep; 54(7):5534-5546. PubMed ID: 27631878
[TBL] [Abstract][Full Text] [Related]
22. Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Ren YL; Jiang Z; Wang JY; He Q; Li SX; Gu XJ; Qi YR; Zhang M; Yang WJ; Cao B; Li JY; Wang Y; Chen YP
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38453793
[TBL] [Abstract][Full Text] [Related]
23. Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
Nguyen MK; McAvoy K; Liao SC; Doric Z; Lo I; Li H; Manfredi G; Nakamura K
Hum Mol Genet; 2022 May; 31(9):1500-1518. PubMed ID: 34791217
[TBL] [Abstract][Full Text] [Related]
24. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
[TBL] [Abstract][Full Text] [Related]
25. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.
Purandare N; Somayajulu M; Hüttemann M; Grossman LI; Aras S
J Biol Chem; 2018 Apr; 293(17):6517-6529. PubMed ID: 29540477
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
Kee TR; Espinoza Gonzalez P; Wehinger JL; Bukhari MZ; Ermekbaeva A; Sista A; Kotsiviras P; Liu T; Kang DE; Woo JA
Front Aging Neurosci; 2021; 13():660843. PubMed ID: 33967741
[TBL] [Abstract][Full Text] [Related]
27. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.
Genin EC; Plutino M; Bannwarth S; Villa E; Cisneros-Barroso E; Roy M; Ortega-Vila B; Fragaki K; Lespinasse F; Pinero-Martos E; Augé G; Moore D; Burté F; Lacas-Gervais S; Kageyama Y; Itoh K; Yu-Wai-Man P; Sesaki H; Ricci JE; Vives-Bauza C; Paquis-Flucklinger V
EMBO Mol Med; 2016 Jan; 8(1):58-72. PubMed ID: 26666268
[TBL] [Abstract][Full Text] [Related]
28. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 and PINK1 mediate CHCHD10
Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
[TBL] [Abstract][Full Text] [Related]
30. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
[TBL] [Abstract][Full Text] [Related]
31. Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population.
Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Guo QH; Wang G
J Alzheimers Dis; 2018; 61(4):1283-1288. PubMed ID: 29376860
[TBL] [Abstract][Full Text] [Related]
32. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
[TBL] [Abstract][Full Text] [Related]
33. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
34. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
[TBL] [Abstract][Full Text] [Related]
35. CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease.
Lu L; Mao H; Zhou M; Lin Y; Dai W; Qiu J; Xiao Y; Mo M; Zhu X; Wu Z; Pei Z; Guo W; Xu P; Chen X
Chin Med J (Engl); 2022 Jul; 135(13):1588-96. PubMed ID: 35830185
[TBL] [Abstract][Full Text] [Related]
36. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.
Sato S; Noda S; Torii S; Amo T; Ikeda A; Funayama M; Yamaguchi J; Fukuda T; Kondo H; Tada N; Arakawa S; Watanabe M; Uchiyama Y; Shimizu S; Hattori N
Hum Mol Genet; 2021 Apr; 30(6):443-453. PubMed ID: 33631794
[TBL] [Abstract][Full Text] [Related]
37. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
[TBL] [Abstract][Full Text] [Related]
38. Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?
Ikeda A; Imai Y; Hattori N
Front Cell Dev Biol; 2022; 10():996061. PubMed ID: 36158221
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
[TBL] [Abstract][Full Text] [Related]
40. Generation of a human iPSC line from a Parkinson's disease patient with a novel CHCHD2 mutation (p.R145Q).
Chen X; Sun J; Wang T; Tang Q; Su L; Sun Y; Chen L; Seo H; Cheng T; Wang J; Song B
Stem Cell Res; 2024 Jun; 77():103419. PubMed ID: 38631182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
